All through the final three months, 12 analysts have evaluated CME Group CME, providing a various set of opinions from bullish to bearish.
Within the desk beneath, you will discover a abstract of their latest scores, revealing the shifting sentiments over the previous 30 days and evaluating them to the earlier months.
Bullish | Considerably Bullish | Detached | Considerably Bearish | Bearish | |
---|---|---|---|---|---|
Complete Scores | 0 | 3 | 7 | 2 | 0 |
Final 30D | 0 | 0 | 0 | 1 | 0 |
1M In the past | 0 | 1 | 0 | 0 | 0 |
2M In the past | 0 | 1 | 4 | 1 | 0 |
3M In the past | 0 | 1 | 3 | 0 | 0 |
Analysts have lately evaluated CME Group and supplied 12-month worth targets. The common goal is $253.17, accompanied by a excessive estimate of $287.00 and a low estimate of $212.00. This upward development is obvious, with the present common reflecting a 4.26% improve from the earlier common worth goal of $242.82.
Understanding Analyst Scores: A Complete Breakdown
The notion of CME Group by monetary specialists is analyzed by way of latest analyst actions. The next abstract presents key analysts, their latest evaluations, and changes to scores and worth targets.
Analyst | Analyst Agency | Motion Taken | Ranking | Present Value Goal | Prior Value Goal |
---|---|---|---|---|---|
Craig Siegenthaler | B of A Securities | Raises | Underperform | $219.00 | $200.00 |
Patrick O’Shaughnessy | Raymond James | Broadcasts | Outperform | $287.00 | – |
Mike Cyprys | Morgan Stanley | Raises | Equal-Weight | $263.00 | $256.00 |
Kyle Voigt | Keefe, Bruyette & Woods | Raises | Market Carry out | $257.00 | $256.00 |
Ashish Sabadra | RBC Capital | Raises | Sector Carry out | $269.00 | $235.00 |
Owen Lau | Oppenheimer | Raises | Outperform | $269.00 | $258.00 |
Kenneth Worthington | JP Morgan | Raises | Underweight | $212.00 | $209.00 |
Benjamin Budish | Barclays | Raises | Equal-Weight | $263.00 | $257.00 |
Kyle Voigt | Keefe, Bruyette & Woods | Lowers | Market Carry out | $256.00 | $260.00 |
Patrick Moley | Piper Sandler | Raises | Chubby | $258.00 | $250.00 |
Ashish Sabadra | RBC Capital | Maintains | Sector Carry out | $235.00 | $235.00 |
Christopher Allen | Citigroup | Lowers | Impartial | $250.00 | $255.00 |
Key Insights:
- Motion Taken: Analysts regularly replace their suggestions based mostly on evolving market situations and firm efficiency. Whether or not they ‘Preserve’, ‘Increase’ or ‘Decrease’ their stance, it displays their response to latest developments associated to CME Group. This info gives a snapshot of how analysts understand the present state of the corporate.
- Ranking: Providing insights into predictions, analysts assign qualitative values, from ‘Outperform’ to ‘Underperform’. These scores convey expectations for the relative efficiency of CME Group in comparison with the broader market.
- Value Targets: Analysts gauge the dynamics of worth targets, offering estimates for the longer term worth of CME Group’s inventory. This comparability reveals tendencies in analysts’ expectations over time.
Analyzing these analyst evaluations alongside related monetary metrics can present a complete view of CME Group’s market place. Keep knowledgeable and make data-driven selections with the help of our Scores Desk.
Keep updated on CME Group analyst scores.
Get to Know CME Group Higher
Primarily based in Chicago, CME Group operates exchanges giving buyers, suppliers, and companies the power to commerce futures and derivatives based mostly on rates of interest, fairness indexes, foreign currency echange, power, metals, and commodities. The Chicago Mercantile Alternate was based in 1898 and in 2002 accomplished its IPO. Since then, CME Group has consolidated elements of the trade by merging with crosstown rival CBOT Holdings in 2007 earlier than buying Nymex Holdings in 2008 and NEX in 2018. As well as, the corporate has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Alternate the unique venue to commerce and clear S&P futures contracts. By way of CME’s acquisition of NEX, it additionally expanded into money overseas alternate, fixed-income buying and selling, and collateral optimization.
CME Group: Monetary Efficiency Dissected
Market Capitalization Evaluation: Above trade benchmarks, the corporate’s market capitalization emphasizes a noteworthy dimension, indicative of a robust market presence.
Income Progress: CME Group’s income progress over a interval of three months has been noteworthy. As of 31 December, 2024, the corporate achieved a income progress charge of roughly 5.98%. This means a considerable improve within the firm’s top-line earnings. As in comparison with its friends, the income progress lags behind its trade friends. The corporate achieved a progress charge decrease than the common amongst friends in Financials sector.
Web Margin: CME Group’s web margin excels past trade benchmarks, reaching 56.62%. This signifies environment friendly value administration and powerful monetary well being.
Return on Fairness (ROE): CME Group’s ROE stands out, surpassing trade averages. With a powerful ROE of 3.16%, the corporate demonstrates efficient use of fairness capital and powerful monetary efficiency.
Return on Property (ROA): CME Group’s ROA lags behind trade averages, suggesting challenges in maximizing returns from its property. With an ROA of 0.63%, the corporate might face hurdles in reaching optimum monetary efficiency.
Debt Administration: The corporate maintains a balanced debt strategy with a debt-to-equity ratio beneath trade norms, standing at 0.13.
Analyst Scores: Simplified
Scores come from analysts, or specialists inside banking and monetary programs that report for particular shares or outlined sectors (sometimes as soon as per quarter for every inventory). Analysts normally derive their info from firm convention calls and conferences, monetary statements, and conversations with essential insiders to succeed in their selections.
Some analysts additionally supply predictions for useful metrics reminiscent of earnings, income, and progress estimates to offer additional steering as to what to do with sure tickers. You will need to take into account that whereas inventory and sector analysts are specialists, they’re additionally human and may solely forecast their beliefs to merchants.
Which Shares Are Analysts Recommending Now?
Benzinga Edge provides you immediate entry to all main analyst upgrades, downgrades, and worth targets. Type by accuracy, upside potential, and extra. Click on right here to remain forward of the market.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.